These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 36964052)

  • 1. Long term SARS-CoV-2-specific cellular immunity after COVID-19 in liver transplant recipients.
    Citores MJ; Caballero-Marcos A; Cuervas-Mons V; Alonso-Fernández R; Graus-Morales J; Arias-Milla A; Valerio M; Muñoz P; Salcedo M
    J Microbiol Immunol Infect; 2023 Jun; 56(3):526-536. PubMed ID: 36964052
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predominantly defective CD8
    Taus E; Shino MY; Ibarrondo FJ; Hausner MA; Hofmann C; Yang OO
    J Transl Med; 2023 Jun; 21(1):374. PubMed ID: 37291575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specific immune response to mRNA vaccines against COVID-19 in patients receiving allogeneic stem cell transplantation for myeloid malignancy was altered by immunosuppressive therapy.
    Macková J; Hainz P; Kryštofová J; Roubalová K; Šťastná-Marková M; Vaníková Š; Musil J; Vydra J; Němečková Š
    Leuk Res; 2023 Jul; 130():107314. PubMed ID: 37216792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cellular Immune Responses to SARS-CoV-2 in Exposed Seronegative Individuals.
    Norton NJ; Holder KA; Ings DP; Harnum DOA; Russell RS; Grant MD
    Viruses; 2023 Apr; 15(4):. PubMed ID: 37112977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. COVID-19 Vaccination Responses with Different Vaccine Platforms in Patients with Inborn Errors of Immunity.
    Erra L; Uriarte I; Colado A; Paolini MV; Seminario G; Fernández JB; Tau L; Bernatowiez J; Moreira I; Vishnopolska S; Rumbo M; Cassarino C; Vijoditz G; López AL; Curciarello R; Rodríguez D; Rizzo G; Ferreyra M; Ferreyra Mufarregue LR; Badano MN; Pérez Millán MI; Quiroga MF; Baré P; Ibañez I; Pozner R; Borge M; Docena G; Bezrodnik L; Almejun MB
    J Clin Immunol; 2023 Feb; 43(2):271-285. PubMed ID: 36251205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T cell-mediated response to SARS-CoV-2 in liver transplant recipients with prior COVID-19.
    Fernández-Ruiz M; Olea B; Almendro-Vázquez P; Giménez E; Marcacuzco A; San Juan R; Justo I; Calvo-Pulido J; García-Sesma Á; Manrique A; Caso O; Cambra F; Talayero P; López-Medrano F; Remigia MJ; Ruiz-Merlo T; Parra P; Paz-Artal E; Jiménez C; Loinaz C; Navarro D; Laguna-Goya R; Aguado JM
    Am J Transplant; 2021 Aug; 21(8):2785-2794. PubMed ID: 34092033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced humoral but stable cellular SARS-CoV-2-specific immunity in liver transplant recipients in the first year after COVID-19.
    Kirchner T; Heinrich S; Bonifacius A; Engel B; Ruhl L; Pink I; Thomas N; Martens J; Hoeper MM; Blasczyk R; Wedemeyer H; Jaeckel E; Li Y; Falk CS; Eiz-Vesper B; Taubert R
    PLoS One; 2022; 17(11):e0276929. PubMed ID: 36322587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coordinated cellular and humoral immune responses after two-dose SARS-CoV2 mRNA vaccination in liver transplant recipients.
    D'Offizi G; Agrati C; Visco-Comandini U; Castilletti C; Puro V; Piccolo P; Montalbano M; Meschi S; Tartaglia E; Sorace C; Leone S; Lapa D; Grassi G; Goletti D; Ippolito G; Vaia F; Ettorre GM; Lionetti R
    Liver Int; 2022 Jan; 42(1):180-186. PubMed ID: 34719107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased Long-Term Severe Acute Respiratory Syndrome Coronavirus 2-Specific Humoral Immunity in Liver Transplantation Recipients 12 Months After Coronavirus Disease 2019.
    Caballero-Marcos A; Citores MJ; Alonso-Fernández R; Rodríguez-Perálvarez M; Valerio M; Graus Morales J; Cuervas-Mons V; Cachero A; Loinaz-Segurola C; Iñarrairaegui M; Castells L; Pascual S; Vinaixa-Aunés C; González-Grande R; Otero A; Tomé S; Tejedor-Tejada J; Fernández-Yunquera A; González-Diéguez L; Nogueras-Lopez F; Blanco-Fernández G; Díaz-Fontenla F; Bustamante FJ; Romero-Cristóbal M; Martin-Mateos R; Arias-Milla A; Calatayud L; Marcacuzco-Quinto AA; Fernández-Alonso V; Gómez-Gavara C; Muñoz P; Bañares R; Pons JA; Salcedo M
    Liver Transpl; 2022 Jun; 28(6):1039-1050. PubMed ID: 34919762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Boosting compromised SARS-CoV-2-specific immunity with mRNA vaccination in liver transplant recipients.
    Luxenburger H; Reeg DB; Lang-Meli J; Reinscheid M; Eisner M; Bettinger D; Oberhardt V; Salimi Alizei E; Wild K; Graeser A; Karl V; Sagar ; Emmerich F; Klein F; Panning M; Huzly D; Bengsch B; Boettler T; Elling R; Thimme R; Hofmann M; Neumann-Haefelin C
    J Hepatol; 2023 May; 78(5):1017-1027. PubMed ID: 36804404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and Immunogenicity After a Three-Dose SARS-CoV-2 Vaccine Schedule in Allogeneic Stem Cell Transplant Recipients.
    Kimura M; Ferreira VH; Kothari S; Pasic I; Mattsson JI; Kulasingam V; Humar A; Mah A; Delisle JS; Ierullo M; Majchrzak-Kita B; Kumar D; Hosseini-Moghaddam SM
    Transplant Cell Ther; 2022 Oct; 28(10):706.e1-706.e10. PubMed ID: 35914727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Robust humoral and cellular immune responses in long-term convalescent COVID-19 individuals following one-dose SARS-CoV-2 inactivated vaccination.
    Liang B; Xiang T; Wang H; Li Z; Quan X; Feng X; Li S; Lu S; Fan L; Xu L; Wang T; Wang X; Zhu B; Wang J; Yang D; Liu J; Zheng X
    Front Immunol; 2022; 13():966098. PubMed ID: 35979361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune Responses to SARS-CoV-2 Vaccination in Young Patients with Anti-CD19 Chimeric Antigen Receptor T Cell-Induced B Cell Aplasia.
    Jarisch A; Wiercinska E; Huenecke S; Bremm M; Cappel C; Hauler J; Rettinger E; Soerensen J; Hellstern H; Klusmann JH; Ciesek S; Bonig H; Bader P
    Transplant Cell Ther; 2022 Jul; 28(7):366.e1-366.e7. PubMed ID: 35472554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of SARS-CoV-2-Specific Humoral and Cellular Immune Responses Induced by Inactivated COVID-19 Vaccines in a Real-World Setting.
    Li Z; Xiang T; Liang B; Deng H; Wang H; Feng X; Quan X; Wang X; Li S; Lu S; Yang X; Wang B; Zelinskyy G; Trilling M; Sutter K; Lu M; Dittmer U; Yang D; Zheng X; Liu J
    Front Immunol; 2021; 12():802858. PubMed ID: 35003131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low seroprevalence of SARS-CoV-2 antibodies in a liver transplant cohort.
    Campos-Varela I; Len O; Villagrasa A; Márquez-Algaba E; Esperalba J; Dopazo C; Los-Arcos I; Antón A; Castells L
    Transpl Int; 2021 Oct; 34(10):1908-1913. PubMed ID: 34121244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of Donor and Recipient SARS-CoV-2 Vaccination or Infection on Immunity after Hematopoietic Cell Transplantation.
    Sherman AC; Cheng CA; Swank Z; Zhou G; Li X; Issa NC; Walt DR; Baden LR; Soiffer RJ
    Transplant Cell Ther; 2023 May; 29(5):337.e1-337.e5. PubMed ID: 36736784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibody Mediated Immunity to SARS-CoV-2 and Human Coronaviruses: Multiplex Beads Assay and Volumetric Absorptive Microsampling to Generate Immune Repertoire Cartography.
    Wang J; Li D; Zhou Q; Wiltse A; Zand MS
    Front Immunol; 2021; 12():696370. PubMed ID: 34386006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined assessment of S- and N-specific IL-2 and IL-13 secretion and CD69 neo-expression for discrimination of post-infection and post-vaccination cellular SARS-CoV-2-specific immune response.
    Kratzer B; Schlax LC; Gattinger P; Waidhofer-Söllner P; Trapin D; Tauber PA; Sehgal ANA; Körmöczi U; Rottal A; Feichter M; Oberhofer T; Grabmeier-Pfistershammer K; Borochova K; Dorofeeva Y; Tulaeva I; Weber M; Mühl B; Kropfmüller A; Negrin B; Kundi M; Valenta R; Pickl WF
    Allergy; 2022 Nov; 77(11):3408-3425. PubMed ID: 35690994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Augmented humoral and cellular immunity against severe acute respiratory syndrome coronavirus 2 after breakthrough infection in kidney transplant recipients who received 3 doses of coronavirus disease 2019 vaccine.
    Yang J; Lee KW; Baek JY; Bae S; Lee YH; Kim H; Huh K; Cho SY; Kang CI; Chung DR; Peck KR; Park JB; Kim SH; Kim TJ; Kim DM; Ko JH
    Am J Transplant; 2023 Apr; 23(4):565-572. PubMed ID: 36739177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SARS-CoV-2 specific T-cell immunity in COVID-19 convalescent patients and unexposed controls measured by ex vivo ELISpot assay.
    Cassaniti I; Percivalle E; Bergami F; Piralla A; Comolli G; Bruno R; Vecchia M; Sambo M; Colaneri M; Zuccaro V; Benazzo M; Robotti C; Calastri A; Maiorano E; Ferrari A; Cambiè G; Baldanti F
    Clin Microbiol Infect; 2021 Jul; 27(7):1029-1034. PubMed ID: 33813122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.